76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Siemens Healthineers AG
Closed
SectorHealthcare
46.92 -0.15
Overview
Share price change
24h
Min
46.64
Max
47.25
Income | 59M 537M |
|---|---|
Sales | 427M 5.9B |
P/E Sector Avg | 25.027 50.291 |
EPS | 0.56 |
Dividend yield | 2.05 |
Profit margin | 9.088 |
Employees | 72,000 |
EBITDA | 116M 1.1B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +28.2% upside |
Dividend yield Sector Avg | 2.05% 2.40% |
|---|---|
Next Earnings | 30 Jul 2025 |
Market Cap | -12B 52B |
|---|---|
Previous open | 47.07 |
Previous close | 46.92 |
News Sentiment
By Acuity
19%
81%
60 / 380 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Siemens Healthineers AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Siemens Healthineers AG Forecast
Price Target
By TipRanks
28.2% upside
12 Months Forecast
Average 60.213 EUR 28.2%
High 67 EUR
Low 50 EUR
Based on 15 Wall Street analysts offering 12 month price targets forSiemens Healthineers AG - Dist in the last 3 months.
Sentiment
By Acuity
60 / 380 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
